Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation.

Chang ML, Yeh CT, Lin DY, Ho YP, Hsu CM, Bissell DM.

BMC Med Genomics. 2009 Aug 8;2:51. doi: 10.1186/1755-8794-2-51.

2.

HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration.

Chang ML, Yeh HC, Tsou YK, Wang CJ, Cheng HY, Sung CM, Ho YP, Chen TH, Yeh CT.

Obesity (Silver Spring). 2012 Jul;20(7):1474-80. doi: 10.1038/oby.2012.45. Epub 2012 Feb 23.

3.

Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.

Kwon YC, Kim H, Meyer K, Di Bisceglie AM, Ray R.

J Immunol. 2016 Aug 15;197(4):1127-36. doi: 10.4049/jimmunol.1600631. Epub 2016 Jun 29.

4.

Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.

Mazumdar B, Kim H, Meyer K, Bose SK, Di Bisceglie AM, Ray RB, Diamond MS, Atkinson JP, Ray R.

J Virol. 2013 Jul;87(14):7902-10. doi: 10.1128/JVI.00917-13. Epub 2013 May 8.

5.

Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice.

Chang ML, Chen JC, Yeh CT, Sheen IS, Tai DI, Chang MY, Chiu CT, Lin DY, Bissell DM.

World J Gastroenterol. 2007 Jul 7;13(25):3472-7.

6.

Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model.

Perlemuter G, Lettéron P, Carnot F, Zavala F, Pessayre D, Nalpas B, Bréchot C.

J Hepatol. 2003 Dec;39(6):1020-7.

PMID:
14642621
7.

Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis.

Chang ML, Yeh CT, Chen JC, Huang CC, Lin SM, Sheen IS, Tai DI, Chu CM, Lin WP, Chang MY, Liang CK, Chiu CT, Lin DY.

BMC Genomics. 2008 Feb 29;9:109. doi: 10.1186/1471-2164-9-109.

8.

Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells.

Moriya K, Miyoshi H, Tsutsumi T, Shinzawa S, Fujie H, Shintani Y, Yotsuyanagi H, Moriishi K, Matsuura Y, Suzuki T, Miyamura T, Koike K.

Am J Pathol. 2009 Oct;175(4):1515-24. doi: 10.2353/ajpath.2009.090102. Epub 2009 Sep 3.

9.

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, Miyamura T, Koike K.

J Gen Virol. 1997 Jul;78 ( Pt 7):1527-31.

PMID:
9225025
10.

Acute expression of hepatitis C core protein in adult mouse liver: Mitochondrial stress and apoptosis.

Chang ML, Chen JC, Chang MY, Yeh CT, Lin WP, Liang CK, Huang SF, Dang KN, Chiu CT, Lin DY.

Scand J Gastroenterol. 2008;43(6):747-55. doi: 10.1080/00365520701875987.

PMID:
18569993
11.

Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.

Tachi Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Samejima Y, Goto H.

Liver Int. 2010 Apr;30(4):554-9. doi: 10.1111/j.1478-3231.2009.02164.x. Epub 2009 Nov 27.

PMID:
19951380
12.

Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.

Koike K.

Hepatol Res. 2005 Oct;33(2):145-50. Epub 2005 Oct 3.

PMID:
16202646
13.

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.

Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, Koike K, Pessayre D, Chapman J, Barba G, Bréchot C.

FASEB J. 2002 Feb;16(2):185-94.

PMID:
11818366
15.

Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.

Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J.

Gastroenterology. 2007 May;132(5):1955-67. Epub 2007 Mar 24.

PMID:
17484888
16.

Hepatitis C virus infection and liver steatosis.

Ramalho F.

Antiviral Res. 2003 Oct;60(2):125-7. Review.

PMID:
14638408
17.

HCV core-mediated activation of latent TGF-β via thrombospondin drives the crosstalk between hepatocytes and stromal environment.

Benzoubir N, Lejamtel C, Battaglia S, Testoni B, Benassi B, Gondeau C, Perrin-Cocon L, Desterke C, Thiers V, Samuel D, Levrero M, Bréchot C, Bourgeade MF.

J Hepatol. 2013 Dec;59(6):1160-8. doi: 10.1016/j.jhep.2013.07.036. Epub 2013 Aug 6.

PMID:
23928402
18.

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K.

Cancer. 2003 Jun 15;97(12):3036-43.

19.
20.

Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus.

Chiyo T, Sekiguchi S, Hayashi M, Tobita Y, Kanegae Y, Saito I, Kohara M.

Virus Res. 2011 Sep;160(1-2):89-97. doi: 10.1016/j.virusres.2011.05.019. Epub 2011 May 30.

PMID:
21645560

Supplemental Content

Support Center